Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized trial of 7-day versus 2-day empirical antibiotics for ICU hospital-acquired infection of unknown origin
2009-015800-25Phase 4Completed
- Sponsor
- Liverpool Heart and Chest Hospital
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of teicoplanin and meropenem in Healthcare-associated infection (HAI) (2 arms), sponsored by Liverpool Heart and Chest Hospital. Primary endpoint: Composite of death or initiation of new antibiotic therapy after completion of allocated treatment. Started Oct 2010; status: completed.
02
Drugs
teicoplaninmeropenem
03
Conditions
Healthcare-associated infection (HAI)
Beyond the preview
Go deeper on 2009-015800-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015800-25.